The influence of glucocorticoid signaling on tumor progression.
about
Human social genomicsDiscovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activityProtecting the normal in order to better kill the cancerPsychoneuroimmunology and cancer: a decade of discovery, paradigm shifts, and methodological innovationsSelective glucocorticoid receptor-activating adjuvant therapy in cancer treatmentsAssociation of lifestyle and demographic factors with estrogenic and glucocorticogenic activity in Mexican American womenA multi-targeted approach to suppress tumor-promoting inflammationPosttraumatic stress disorder-like induction elevates β-amyloid levels, which directly activates corticotropin-releasing factor neurons to exacerbate stress responses.Gene expression of peripheral blood cells reveals pathways downstream of glucocorticoid receptor antagonism and nab-paclitaxel treatment.Day-to-day dynamics of associations between sleep, napping, fatigue, and the cortisol diurnal rhythm in women diagnosed as having breast cancerBiobehavioral approaches to cancer progression and survival: Mechanisms and interventionsDiurnal cortisol and survival in epithelial ovarian cancerStress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damageSynthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor.Stress management reduces intraindividual cortisol variability, while not impacting other measures of cortisol rhythm, in a group of women at risk for breast cancer.Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.The pro-social neurohormone oxytocin reverses the actions of the stress hormone cortisol in human ovarian carcinoma cells in vitroPterostilbene Decreases the Antioxidant Defenses of Aggressive Cancer Cells In Vivo: A Physiological Glucocorticoids- and Nrf2-Dependent MechanismInteraction of glucocorticoid receptor (GR) with estrogen receptor (ER) α and activator protein 1 (AP1) in dexamethasone-mediated interference of ERα activitySex differences in the HPA axis.Adrenal clocks and the role of adrenal hormones in the regulation of circadian physiology.Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor.Depression, Antidepressant Use, and Postmenopausal Breast Cancer Risk.The transrepression arm of glucocorticoid receptor signaling is protective in mutant huntingtin-mediated neurodegeneration.Exposure to road traffic and railway noise and postmenopausal breast cancer: A cohort study.Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1.The Immunoexpression of Glucocorticoid Receptors in Breast Carcinomas, Lactational Change, and Normal Breast Epithelium and Its Possible Role in Mammary Carcinogenesis.The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments.A dual role for glucocorticoid-induced leucine zipper in glucocorticoid function: tumor growth promotion or suppression?Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.Association of child maltreatment subtypes and long-term physical health in a German representative sample
P2860
Q21092402-38BE0594-3596-4792-8715-C0D7A9B9F968Q26782111-C53E0FDA-5978-47CD-91F1-0DEF963612ABQ26801291-B9006C06-FE75-41CD-B1E5-4824587D298CQ27007708-BD9624DA-6D92-45DB-88A9-232DACF60911Q28078896-96708C2E-9AF1-482E-8456-5F582FF0FC28Q28388192-5BEBF906-291C-4644-925B-462BBB584A94Q28393278-94462F3C-1FAC-4E83-AC9D-6C11F98B16F2Q30405044-B403F2C7-35D6-4B86-B5A6-A462397D0D3EQ34005665-EBE602BC-764C-4F93-A468-777F844F99AEQ34175355-1906F95E-6278-4200-B57C-A94A088AC3F5Q35142020-C966E1AB-FB0B-4DBF-935C-538A71014BE8Q35634097-28749815-A72B-4E69-9923-F8181CAF7076Q35677932-7507D1CD-F63F-42DA-93D4-C9B5030CBC54Q35894035-EA3E55DC-6BF6-4986-BF62-94F052F06331Q36609338-00187CF1-848C-47BB-85A7-E46F73E43D7CQ36707715-1AB33B56-0E1A-4B67-9663-351AB4C9FB7BQ36734187-99A50696-45DF-4B1C-9718-76C4D5CE5A2FQ37040056-2D5BCE24-32E7-49FF-945F-999160E41C98Q37099757-8DC84035-19FF-4724-97A8-EC02A51F5598Q38221452-EC31D170-4E07-45A8-B752-316A0FA83228Q38264864-1B6FA08F-6120-4FB3-ABFF-F9AA6D4EBBA6Q38739362-6CBEB355-7B2C-42D6-9548-25D3300DFC03Q41117152-2F567021-DC74-4C6C-8C10-28A65B3FA98BQ41244698-D0B753D2-C407-4AA9-A1E6-F0D2C9E2B9CCQ43457861-BE51F3E5-873D-4155-BF4B-2956C9E78932Q46611038-6B1B6B9A-A401-437E-90D1-D83F8B566CDFQ47123500-F8448F3C-FB13-4C13-8E3D-6CEE090C8D8DQ48214161-4257EC66-CB48-4620-92AB-BF68DF174246Q48291586-039C6861-0D6A-4CB8-824C-F14BCA59812DQ55341418-B08DF0E6-6446-4476-BB5F-74E48F91C963Q55384201-E1323C76-3449-475F-9513-F36C1D925164Q55554673-3DB030C9-DD4F-4B47-95D6-150A8119394FQ58759044-DB04E7A4-AD85-4927-930C-BE63509EA0F6
P2860
The influence of glucocorticoid signaling on tumor progression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The influence of glucocorticoid signaling on tumor progression.
@en
The influence of glucocorticoid signaling on tumor progression.
@nl
type
label
The influence of glucocorticoid signaling on tumor progression.
@en
The influence of glucocorticoid signaling on tumor progression.
@nl
prefLabel
The influence of glucocorticoid signaling on tumor progression.
@en
The influence of glucocorticoid signaling on tumor progression.
@nl
P2860
P1476
The influence of glucocorticoid signaling on tumor progression.
@en
P2093
Paul A Volden
Suzanne D Conzen
P2860
P304
P356
10.1016/J.BBI.2012.10.022
P478
P577
2012-11-16T00:00:00Z